1. Home
  2. CTSO vs MAXN Comparison

CTSO vs MAXN Comparison

Compare CTSO & MAXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTSO
  • MAXN
  • Stock Information
  • Founded
  • CTSO 1997
  • MAXN 2019
  • Country
  • CTSO United States
  • MAXN Singapore
  • Employees
  • CTSO N/A
  • MAXN N/A
  • Industry
  • CTSO Medical/Dental Instruments
  • MAXN Semiconductors
  • Sector
  • CTSO Health Care
  • MAXN Technology
  • Exchange
  • CTSO Nasdaq
  • MAXN Nasdaq
  • Market Cap
  • CTSO 61.3M
  • MAXN 61.7M
  • IPO Year
  • CTSO N/A
  • MAXN N/A
  • Fundamental
  • Price
  • CTSO $1.03
  • MAXN $2.86
  • Analyst Decision
  • CTSO Strong Buy
  • MAXN Sell
  • Analyst Count
  • CTSO 3
  • MAXN 6
  • Target Price
  • CTSO $4.67
  • MAXN $195.80
  • AVG Volume (30 Days)
  • CTSO 74.6K
  • MAXN 170.3K
  • Earning Date
  • CTSO 05-08-2025
  • MAXN 05-29-2025
  • Dividend Yield
  • CTSO N/A
  • MAXN N/A
  • EPS Growth
  • CTSO N/A
  • MAXN N/A
  • EPS
  • CTSO N/A
  • MAXN N/A
  • Revenue
  • CTSO $35,594,520.00
  • MAXN $689,010,000.00
  • Revenue This Year
  • CTSO $18.72
  • MAXN N/A
  • Revenue Next Year
  • CTSO $19.75
  • MAXN $34.68
  • P/E Ratio
  • CTSO N/A
  • MAXN N/A
  • Revenue Growth
  • CTSO 14.51
  • MAXN N/A
  • 52 Week Low
  • CTSO $0.70
  • MAXN $2.49
  • 52 Week High
  • CTSO $1.61
  • MAXN $410.00
  • Technical
  • Relative Strength Index (RSI)
  • CTSO 53.19
  • MAXN 40.90
  • Support Level
  • CTSO $0.93
  • MAXN $2.68
  • Resistance Level
  • CTSO $1.07
  • MAXN $3.35
  • Average True Range (ATR)
  • CTSO 0.06
  • MAXN 0.33
  • MACD
  • CTSO 0.01
  • MAXN 0.05
  • Stochastic Oscillator
  • CTSO 71.43
  • MAXN 43.07

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About MAXN Maxeon Solar Technologies Ltd.

Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, France, Italy, and others.

Share on Social Networks: